Journals / Anadolu Kardiyoloji Dergisi / 2012 / Cilt: 12 - Sayı: 6

Is pseudoexfoliation syndrome a risk factor for cardiovascular diseases?

Psödoeksfoliyasyon sendromu kardiyovasküler hastalıklar için bir risk faktörü müdür?

Pages
488–489
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

YOKUŞOĞLU, M. (2022). Is pseudoexfoliation syndrome a risk factor for cardiovascular diseases?. Anadolu Kardiyoloji Dergisi, Cilt: 12 - Sayı: 6, 488–489. https://ajindex.com/articles/436492

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ritch R, Schlötzer-Schrehardt U. Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmol Scand 2001
  2. [CrossRef] 2. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006
  3. [CrossRef] 3. Ritch R, Schlötzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol 2001
  4. [CrossRef] 4. Ritch R. Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma. J Glaucoma 1994
  5. [CrossRef] 5. Schlötzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992
  6. [CrossRef] 6. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992
  7. [CrossRef] 7. Paliobei VP, Psillas GK, Mikropoulos DG, Haidich AB, Constantinidis J, Konstas AG. Hearing evaluation in patients with exfoliative and primary open-angle glaucoma. Otolaryngol Head Neck Surg 2011
  8. [CrossRef] 8. Abu-Amero KK, Kondkar AA, Mousa A, Osman EA, Al-Obeidan SA. Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma. Mol Vis 2011
  9. Cumurcu T, Gündüz A, Özyurt H, Nurçin H, Atiş O, Eğri M. Increased oxidative stress in patients with pseudoexfoliation syndrome. Ophthalmic Res 2010
  10. [CrossRef] 10. Altıntaş O, Yüksel N, Sönmez GT, Özkan B, Altıntaş L, Calışkan S, et al. Serum antiphospholipid antibody levels in pseudoexfoliation. J Glaucoma 2011 Mar 16. [Epub ahead of print] 11. Browne JG, Ho SL, Kane R, Oliver N, Clark AF, O'Brien CJ, et al. Connective tissue growth factor is increased in pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci 2011
  11. [CrossRef] 12. Visontai Z, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma 2008
  12. [CrossRef] 13. Praveen MR, Shah SK, Vasavada AR, Diwan RP, Shah SM, Zumkhawala BR, et al. Pseudoexfoliation as a risk factor for peripheral vascular disease: a case-control study. Eye (Lond) 2011
  13. [CrossRef] 14. Yağcı R, Ersöz I, Aydın B, Beyaz E, Gürel A, Durmuş M, et al. Aqueous humor and serum concentration of hydroxyproline in pseudoexfoliation syndrome. J Glaucoma 2007
  14. [CrossRef] 15. Roedl JB, Bleich S, Reu